ArticleScience advancesPublished
P300/CBP inhibition with inobrodib in combination with gilteritinib and venetoclax targets leukemia stem cells in epigenetic mutant AML
Regional connection
Verified Author affiliations on the Europe PMC record name Thomas Jefferson University, University of Pennsylvania. Affiliation source
- Institutions
- Thomas Jefferson University, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Science advances
- Published
- Topic
- Disease research
- Subject terms
- Cell Line, Tumor; Animals; Humans; Mice; Sulfonamides; Aniline Compounds; Imidazoles; Oxazoles; Pyrazines; Epigenesis, Genetic; Mutation; p300-CBP Transcription Factors
- PubMed ID
- 42139346
- PubMed Central ID
- PMC13178526
- Open access
- Yes, open
- Added to directory
- Source checked